Results 101 to 110 of about 17,134,916 (313)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Report of the Council of the University of the Cape of Good Hope nineteen hundred and two

open access: yes, 2015
Report of the proceedings of the University of the Cape of Good Hope during 1902.Official 1902 Report of the Council of the University of the Cape of Good Hope to the Cape Colonial Parliament.

core  

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Report of the Council of the University of the Cape of Good Hope nineteen hundred and six

open access: yes, 2015
Report of the proceedings of the University of the Cape of Good Hope during 1906.Official 1906 Report of the Council of the University of the Cape of Good Hope to the Cape Colonial Parliament.

core  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Report of the Council of the University of the Cape of Good Hope nineteen hundred and seven

open access: yes, 2015
Report of the proceedings of the University of the Cape of Good Hope during 1907.Official 1907 Report of the Council of the University of the Cape of Good Hope to the Cape Colonial Parliament.

core  

Public interests, private disputes: Investment arbitration and the public good [PDF]

open access: yes, 2016
This paper seeks to investigate the bases for resistance to arbitration in general -and investor arbitration in particular- focusing on the way in which arbitral tribunals deal with notions of public interest and the public good.
Glinavos, I.
core  

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

Public Health A Public Good

open access: yesAmrita Journal of Medicine, 2023
Unnikrishnan Menon
doaj   +1 more source

Deliberative leadership: Sustainable practices for public universities?

open access: yesJPHE
The higher education landscape is experiencing a period of serious uncertainty, an interregnum wherein there is considerable disagreement as to its orientation and sustainability.
Ciaran Sugrue, Tone Dyrdal Solbrekke
doaj   +1 more source

Home - About - Disclaimer - Privacy